Clinical radiobiology of squamous cell carcinoma of the oropharynx.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  1991-06-01

• Fields of study

  Medicine, Physics

• Identifiers
  DOI 10.1016/0360-3016(91)90228-VPMID 2045294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Time-dose factors in radiotherapy: a review of the human data.

  1990cited by this paper
• New options in direct analysis of dose-response data.

  1990cited by this paper
• Further analysis of the time factor in squamous cell carcinoma of the tonsillar region.

  1990cited by this paper
• Squamous cell carcinoma of the oropharynx: An analysis of 213 consecutive patients scheduled for primary radiotherapy

  1990cited by this paper
• Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses: acute and late effects.

  1990cited by this paper
• Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation.

  1990cited by this paper
• Does variation in the in vitro cellular radiosensitivity explain the shallow clinical dose-control curve for malignant melanoma?

  1990cited by this paper
• Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study.

  1989cited by this paper
• Sensitization of hypoxic tumour cells--clinical experience.

  1989cited by this paper
• The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: based on RTOG trial #79-15.

  1989cited by this paper
• Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.

  1989cited by this paper
• Clinical radiobiology of malignant melanoma.

  1989cited by this paper
• Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study.

  1989cited by this paper
• A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: clinical and treatment parameters as prognostic factors.

  1989cited by this paper
• Direct estimation of latent time for radiation injury in late-responding normal tissues: gut, lung, and spinal cord.

  1989cited by this paper
• Fractionation parameters for human tissues and tumors.

  1989cited by this paper
• The hazard of accelerated tumor clonogen repopulation during radiotherapy.

  1988cited by this paper
• Regional outcome in oropharyngeal and pharyngolaryngeal cancer treated with high dose per fraction radiotherapy. Analysis of neck disease response in 1646 cases.

  1986cited by this paper
• Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival.

  1986cited by this paper
• Klaas Breur Medal lecture 1985. The growth and progression of human tumors: implications for management strategy.

  1986cited by this paper
• Carcinoma of the tonsil: the effect of dose-time-volume factors on local control.

  1985cited by this paper
• A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation.

  1985cited by this paper
• Relationship between lymph nodal status and primary tumor control probability in tumors of the supraglottic larynx.

  1985cited by this paper
• Predicting the response of head and neck cancers to radiation therapy with a multivariate modelling system: an analysis of the RTOG head and neck registry.

  1984cited by this paper
• Management of head and neck cancer

  1984cited by this paper
• Analysis of the results of irradiation in the treatment of tonsillar region carcinomas.

  1983cited by this paper
• Accelerated fractionation vs hyperfractionation: rationales for several treatments per day.

  1983cited by this paper
• Algorithm 611: Subroutines for Unconstrained Minimization Using a Model/Trust-Region Approach

  1983cited by this paper
• Carcinoma of the tonsillar fossa. A nonrandomized comparison of preoperative radiation and surgery or irradiation alone: Long‐term results

  1982cited by this paper
• Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships.

  1982cited by this paper
• Clonogenic potential of human tumors. A hypothesis.

  1981cited by this paper
• A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck.

  1980cited by this paper
• Laryngeal carcinoma. IV. Analysis of treatment results using the Cohen model.

  1980cited by this paper
• The Third Annual Lectureship of the Juan A. del Regato Foundation. Squamous cell carcinomas of the oropharynx.

  1979cited by this paper
• An analysis of factors in the successful management of cancer of tonsillar region

  1978cited by this paper
• A model for a binary variable with time-censored observations

  1977cited by this paper
• An analysis of factors in the successful management of cancer of the tonsillar region

  1977cited by this paper
• Results of irradiation in squamous cell carcinomas of the glossopalatine sulcus.

  1976cited by this paper
• The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation.

  1976cited by this paper
• Time, dose, and tumor volume relationships in irradiation of squamous cell carcinomas of the base of the tongue

  1976cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper
• A cell population kinetic model for fractionated radiation therapy. I. Normal tissues.

  1971cited by this paper
• The relation between tumour lethal doses and the radiosensitivity of tumour cells.

  1961cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Managing unplanned radiotherapy interruptions in Italy: results from an AIRO survey.

  2026cites this paper
• Unveiling the impact of modified cell death models on hypofractionated radiation therapy efficacy

  2025cites this paper
• Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumors

  2023cites this paper
• Radiotherapy interruption due to holidays adversely affects the survival of patients with nasopharyngeal carcinoma: a joint analysis based on large-scale retrospective data and clinical trials

  2022influential citation
• Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system

  2022cites this paper
• Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea

  2021cites this paper
• Altering Radiation Response with Time, Volume and Fractionation

  2021cites this paper
• Locoregional Radionuclide Cancer Therapy: Clinical and Scientific Aspects

  2021cites this paper
• Impact of delays in radiotherapy of head and neck cancer on outcome

  2020influential citation
• Cancer Radiotherapy: General Considerations and Human Radiobiology

  2020cites this paper
• Awareness and surveillance of radiation treatment schedules reduces head and neck overall treatment time

  2019cites this paper
• Prognostic impact of tumor growth velocity in head and neck squamous cell carcinoma treated by radiotherapy: A pilot study

  2019cites this paper
• Photon iso-effective dose for cancer treatment with mixed field radiation based on dose–response assessment from human and an animal model: clinical application to boron neutron capture therapy for head and neck cancer

  2017cites this paper
• SPLIT-COURSE ACCELERATED HYPERFRACTIONATED RADIOTHERAPY IN HEAD AND NECK CARCINOMA- AN EXPERIENCE IN TERMS OF LOCAL TUMOUR CONTROL AND TOXICITY

  2017cites this paper
• Management of interruptions to fractionated radiotherapy treatments: Four and a half years of experience.

  2016cites this paper
• Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature.

  2015cites this paper
• Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy

  2015cites this paper
• Risk factors and prediction-score model for distant metastasis

  2015cites this paper
• The end of the hypoxic EPOch.

  2015cites this paper
• Use of Proktis-M suppositories in patients undergoing neoadjuvant radiochemotherapy for adenocarcinoma of the rectum.

  2015cites this paper
• Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer

  2014cites this paper
• Imaging of Nasopharyngeal Carcinoma

  2014cites this paper
• 9.04 – Modeling of Radiation Effects in Cells and Tissues

  2014cites this paper
• Estimate of the accelerated proliferation by protein tyrosine phosphatase (PTEN) over expression in postoperative radiotherapy of head and neck squamous cell carcinoma

  2013cites this paper
• Correlation between egfr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma

  2012cites this paper
• State-based simulations of tumor response to radiotherapy

  2012cites this paper
• 6 Imaging of Nasopharyngeal Carcinoma

  2012cites this paper
• Image cytometric nuclear texture features in inoperable head and neck cancer: a pilot study

  2011cites this paper
• Tonsillar carcinomas in Norway, changes in etiology and prognosis

  2011cites this paper
• Treatment Results and Prognostic Factors of Pharyngeal Carcinoma Treated with Either Radiotherapy Alone or in Combination with Systemic Chemotherapy

  2011cites this paper
• Estimating Cure Rates From Survival Data: An Alternative to Two-Component Mixture Models

  2010cites this paper
• Treatment interruption among head and neck cancer patients undergoing radical radiotherapy

  2010cites this paper
• Imaging in the Diagnosis and Staging of Carcinoma of Nasopharynx

  2010cites this paper
• [How long is it reasonable to wait for radiotherapy].

  2009cites this paper
• Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays

  2009cites this paper
• QUAL O TEMPO QUE É LEGÍTIMO ESPERAR POR RADIOTERAPIA

  2009cites this paper
• Morbidity and quality of life among head and neck cancer patients treated with radical radiotherapy.

  2009cites this paper
• Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays

  2009cites this paper
• Fundamental Radiobiology and its Application to Radiation Oncology

  2009cites this paper
• Radiosensitivity of squamous cell carcinoma metastases to the neck assessed by immunocytochemical profiling of fine-needle aspiration biopsy cell specimens: a pilot study.

  2009cites this paper
• Onset time of tumor repopulation for cervical cancer: first evidence from clinical data.

  2009cites this paper
• Neoplasms of the Nasopharynx

  2008cites this paper
• The timely delivery of radical radiotherapy : standards and guidelines for the management of unscheduled treatment

  2008cites this paper
• Tumor progression in waiting time for radiotherapy in head and neck cancer.

  2007cites this paper
• 10 Inter-tumour heterogeneity and tumour control

  2007cites this paper
• Radiotherapy predictive assays

  2007cites this paper
• The Predictive Value of Detailed Histological Staging of Surgical Resection Specimens in Oral Cancer

  2007cites this paper
• Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparison.

  2007cites this paper
• Egyetemi Doktori (Ph.D.) Értekezés Szájüregi laphámrákok vizsgálata az észak-kelet magyarországi régióban Etiológiai tényezQk és prognosztikai faktorok

  2006cites this paper
• Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma.

  2006cites this paper
• Association of haemoglobin level with morbidity and mortality of patients with locally advanced oesophageal carcinoma undergoing radiotherapy--a secondary analysis of three consecutive clinical phase III trials.

  2006cites this paper
• Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response.

  2006cites this paper
• Prognostic Value of Tumor Volume in Nasopharyngeal Carcinoma

  2005cites this paper
• [Anemia in head and neck cancers].

  2005cites this paper
• Managing anemia with epoetin alfa in patients with rectal cancer

  2005cites this paper
• Inoperable oropharyngeal carcinoma treated with concomitant irradiation, mitomycin C and bleomycin - long term results.

  2005cites this paper
• The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma

  2005cites this paper
• Clinical radiobiology of stage T2-T3 bladder cancer.

  2004cites this paper
• Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control.

  2004cites this paper
• Blood Hemoglobin Level and Treatment Outcome of Early Breast Cancer

  2004cites this paper
• Different prognostic indices in 310 patients with tonsillar carcinomas

  2003cites this paper
• Protracted Radiotherapy Treatment Duration in Medulloblastoma

  2003cites this paper
• Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas.

  2003cites this paper
• Multivariate Analysis of Prognostic Factors in 1 252 Consecutive Patients Treated with Primary Radiotherapy

  2003cites this paper
• Tumor cell repopulation during conventional and accelerated radiotherapy in the in vitro megacolony culture.

  2003cites this paper
• Radiotherapy for squamous cell carcinoma of the oropharynx: long term results and multivariate analysis of prognostic factors

  2003cites this paper
• Segmentation and visualization of nasopharyngeal carcinoma using MRI

  2003cites this paper
• Estimating Cure Rates From Survival Data

  2003cites this paper
• Optimisation of conformal radiation therapy by intensity modulation: cancer of the larynx and salivary gland function.

  2003cites this paper
• Hemoglobin as an Independent Prognostic Factor in the Radiotherapy of Head and Neck Tumors

  2003cites this paper
• Radiotherapy and chemotherapy

  2002cites this paper
• The Effects of Epoetin Alfa on Transfusion Requirements in Head and Neck Cancer Patients: A Prospective, Randomized, Placebo‐Controlled Study

  2002cites this paper
• How fast is repopulation of tumor cells during the treatment gap?

  2002cites this paper
• GLOTTIC CANCER TREATED WITH DEFINITIVE RADIOTHERAPY ALONE : EXPERIENCE OF THE CANCER HOSPITAL OF PEKING UNION MEDICAL COLLEGE AND THE CHINESE ACADEMY OF MEDICAL SCIENCES

  2002cites this paper
• Prognosefaktoren bei Kopf-Hals-Karzinomen

  2002cites this paper
• Cancer of the oropharynx.

  2002cites this paper
• Pathological Response to Preoperative Chemoradiation Worsens with Anemia in Non‐‐‐Small Cell Lung Cancer Patients

  2002cites this paper
• Analysis of prognostic factors for T(1)N(0)M(0) glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy Of Medical Sciences.

  2002cites this paper
• [Prognostic factors in head-neck carcinomas].

  2002cites this paper
• Rationales, evidence, and design considerations for fractionated radioimmunotherapy

  2002cites this paper
• The use of the linear quadratic model in radiotherapy: a review

  2001cites this paper
• Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx.

  2001cites this paper
• Primary tumour volume delineation in nasopharyngeal carcinoma and correlation with 1997 AJCC tumour stage classification.

  2001cites this paper
• Predictive Value of the Tumor Oxygenation by Means of pO2 Histography in Patients with Advanced Head and Neck Cancer

  2001cites this paper
• Time-dose-response relationships in postoperatively irradiated patients with head and neck squamous cell carcinomas.

  2001cites this paper
• Split-Course Radiotherapy: Where Do We Stand?

  2001cites this paper
• Concurrent Chemoradiotherapy for Oropharyngeal Carcinoma

  2001cites this paper
• Hypopharyngeal Squamous Cell Carcinoma: Treatment Results in 138 Consecutively Admitted Patients

  2000cites this paper
• Carcinoma of the Oropharynx: Local Failure as the Decisive Parameter for Distant Metastases and Survival

  2000cites this paper
• Single-dose versus fractionated radioimmunotherapy: model comparisons for uniform tumor dosimetry.

  2000cites this paper
• An analysis of the relationship between radiosensitivity and volume effects in tumor control probability modeling.

  2000cites this paper
• Anemia is associated with decreased local control of surgically treated squamous cell carcinomas of the glottic larynx.

  2000cites this paper
• What is the dose-limiting for altered radiotherapy for head and neck cancers - facts and doubts

  2000cites this paper
• Radioterapia experimental. Parámetros de respuesta tumoral a la radiación

  2000cites this paper
• In response to Drs. King and Mayo: low α/β values for prostate appear to be independent of modeling details1

  2000cites this paper
• Significance of Hemoglobin Concentration for Treatment Outcome

  2000cites this paper
• Spline-based estimation of cure rates: An application to the analysis of breast cancer data

  2000cites this paper
• How Treatment Gaps Effect Tumour Control Probability

  2000cites this paper
• Erythropoietin for patients undergoing radiotherapy: a pilot study.

  1999cites this paper
• Accounting for treatment delays when treating highly proliferative tumours.

  1999cites this paper